The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Real-world evidence in the treatment of ovarian cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Vergote, I., Tropé, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., Verheijen, R. H. M., van der Burg, M. E. L., Lacave, A. J., Panici, P. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908806 · Cited by 2,537
Kehoe, S., Hook, J., Nankivell, M., Jayson, G. C., Kitchener, H., Lopes, T., Luesley, D., Perren, T., Bannoo, S., Mascarenhas, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62223-6 · Cited by 1,414
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Booth, C. M., & Tannock, I. F. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.725 · Cited by 469
Wright, A. A., Bohlke, K., Armstrong, D. K., Bookman, M. A., Cliby, W. A., Coleman, R. L., Dizon, D. S., Kash, J. J., Meyer, L. A., Moore, K. N., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.6907 · Cited by 409
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
Wright, A. A., Cronin, A., Milne, D. E., Bookman, M. A., Burger, R. A., Cohn, D. E., Cristea, M. C., Griggs, J. J., Keating, N. L., Levenback, C. F., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4776 · Cited by 185
Global trends and predictions in ovarian cancer mortality
Malvezzi, M., Carioli, G., Rodríguez, T., Negri, E., & Vecchia, C. L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw306 · Cited by 149
Rosen, B. P., Laframboise, S., Ferguson, S. E., Dodge, J. E., Bernardini, M. Q., Murphy, J., Segev, Y., Sun, P., & Narod, S. A. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.004 · Cited by 119
Rauh‐Hain, J. A., Melamed, A., Wright, A. A., Gockley, A. A., Clemmer, J. T., Schorge, J. O., Carmen, M. G. D., & Keating, N. L. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4411 · Cited by 111
Perioperative chemotherapy for muscle‐invasive bladder cancer: A population‐based outcomes study
Booth, C. M., Siemens, D. R., Li, G., Peng, Y., Tannock, I. F., Kong, W., Berman, D. M., & Mackillop, W. J. (2014) · Cancer · doi:10.1002/cncr.28510 · Cited by 93
Yang, H., Anderson, W. F., Rosenberg, P. S., Trabert, B. L., Gierach, G. L., Wentzensen, N., Cronin, K. A., & Sherman, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5758 · Cited by 85
Ovarian cancer in France: Trends in incidence, mortality and survival, 1980–2012
Trétarre, B., Molinié, F., Woronoff, A., Bossard, N., Bessaoud, F., Marrer, É., Grosclaude, P., Guizard, A., Delafosse, P., Bara, S., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.09.013 · Cited by 47
Cited by
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566511 · Cited by 392
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
Ramaiah, M. J., Tangutur, A. D., & Manyam, R. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119504 · Cited by 345
Shuford, S., Wilhelm, C., Rayner, M., Elrod, A., Millard, M., Mattingly, C., Lotstein, A., Smith, A. M., Guo, Q. J., O’Donnell, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47578-7 · Cited by 66
Metadata
- Authors
- Eisenhauer, E. A.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 28
- Issue
- suppl_8
- Pages
- viii61-viii65
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2775269156
- Cited by
- 344
- References
- 12
- FWCI
- 21.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.